Company page
Argenx Se
Argenx SE is a public company listed on the Belgium market under the ticker ARGX. The company has a market capitalization of approximately €54.1 billion. Argenx focuses on developing innovative therapies for patients with severe autoimmune diseases and cancer.
- Ticker
- ARGX:EURONEXT
- Asset type
- Stock
- Market cap
- $54.09B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- EURONEXT
- Currency
- EUR